Every engagement is different. These are real situations, real work, and real outcomes. Details have been changed to protect client confidentiality.
All case studies are anonymised. Identifying details including names, locations, specific conditions, and institutional names have been altered or generalised to protect client confidentiality. The substance of the work and the outcomes are accurate.
Her consultant recommended a full hysterectomy following an abnormal scan result. She was given a date within three weeks and told it was routine. No second opinion was offered. She came to me because something felt rushed.
I pulled the published outcomes data for the specific procedure being recommended against her scan findings. The complication rate for her age bracket and existing conditions was significantly higher than what she'd been quoted verbally. I also identified two less invasive alternatives with comparable five-year outcomes that hadn't been discussed. I wrote her a 14-page briefing and prepared a list of questions for her follow-up consultation.
She took the briefing to her consultant. He agreed to pursue the less invasive option. Twelve months later, the issue is resolved and she avoided major surgery entirely. Her words: "Nobody had shown me the numbers before. I would have gone ahead without questioning it."
A man in his early 40s had been experiencing chronic fatigue, joint pain, and cognitive fog for over two years. Blood tests repeatedly came back "normal." He'd been told it was stress, then anxiety, then age. He was starting to doubt himself.
I reviewed every blood test result he had from the past three years. The standard panels were indeed within range, but I noticed his ferritin was technically "normal" at 22 while sitting at the very bottom of the reference range. I also identified that his vitamin D, B12, and magnesium had never been tested together. I cross-referenced his symptom cluster against published diagnostic criteria for three conditions his GPs hadn't considered. I wrote the referral rationale and identified a specialist with specific experience in his symptom profile.
The specialist ran the tests I'd flagged. He was diagnosed with an autoimmune condition that had been missed because his inflammatory markers presented atypically. He's now on treatment and reports 80% symptom improvement. He'd been six months away from requesting a mental health referral he didn't need.
A daughter contacted me about her 78-year-old mother who'd been deteriorating over six months. Increased confusion, falls, loss of appetite. The family assumed it was age-related decline. The mother was being managed by a GP, a cardiologist, and a rheumatologist, none of whom had a complete picture of her full medication list.
I compiled her full medication list from all three prescribers and ran a comprehensive interaction analysis. I found that one statin was known to interact with her arthritis medication in a way that significantly increased fall risk. A second interaction between her blood pressure medication and a newer prescription was flagged in the literature as contributing to cognitive decline in elderly patients. None of these interactions appeared on standard pharmacy checks because each prescription was being dispensed separately. I wrote the briefing with full citations and a suggested medication review agenda for her GP.
The GP reviewed the briefing and agreed to adjust two of the flagged medications. Within eight weeks, the mother's confusion had reduced noticeably, the falls stopped, and her appetite returned. The daughter told me: "We'd accepted this was just what getting old looked like. It wasn't."
An Arabic-speaking family with members in London, Dubai, and Amman. The father had a cardiac condition being managed in the UAE. The mother was seeing a specialist in London. Their teenage son had a developmental concern being assessed in Jordan. Three healthcare systems, three languages of medical documentation, and nobody connecting the dots.
I became their single point of contact. I obtained and translated all medical records into a unified file. I coordinated appointment schedules across time zones. For the father, I identified that his UAE cardiologist's protocol differed from current UK and US guidelines in a way that warranted discussion. For the son, I researched the specific assessment being used in Jordan and compared it against the UK gold standard, identifying a gap that the family's Amman-based doctor wasn't aware of. Monthly briefings in Arabic. Encrypted communications throughout.
The father's protocol was adjusted after his cardiologist reviewed the comparative evidence I prepared. The son received a more comprehensive assessment that changed his support plan. The mother told me, in Arabic: "For the first time, I feel like someone actually understands our whole situation, not just the bit they can see in their clinic." Engagement ongoing.
A man in his mid-40s had been following a longevity protocol recommended by a private clinic. NAD+ injections, peptide therapy, 14 daily supplements, quarterly blood panels. Monthly cost: over £1,200. He felt fine, but wanted to know if any of it was actually working, or if he was paying for expensive placebo.
I audited every element of his protocol against published evidence. For each supplement, I checked whether there was robust human trial data supporting the claimed benefit at the dose he was taking. For his NAD+ protocol, I reviewed the current state of the research and compared what his clinic was claiming against what the literature actually shows. Seven of his 14 supplements had no meaningful evidence at his dosage. Two were potentially counterproductive given his blood panel trends. Three were genuinely supported. I wrote a 22-page briefing with a recommended revised protocol.
He dropped seven supplements and renegotiated his clinic arrangement. His monthly spend went from £1,200 to £400, and his six-month blood panel results were unchanged or improved. He told me: "I knew some of it was probably rubbish, but I didn't have anyone willing to actually check."
A woman in her early 30s had been experiencing severe menstrual pain and heavy periods lasting seven to nine days every cycle since her late teens. She'd been prescribed the pill at 16, came off it at 28, and the symptoms returned worse than before. Her GP told her heavy periods were "just how some women are." She'd tried evening primrose oil, hot water bottles, and ibuprofen on repeat. A friend mentioned endometriosis but her GP said a scan showed nothing. She came to me exhausted, anaemic, and missing two days of work every month.
I pulled the current literature on menstrual dysfunction and mapped her symptoms against published diagnostic criteria for endometriosis, PCOS, and oestrogen dominance. Her GP had only run a standard ultrasound, but endometriosis doesn't show on ultrasound in most cases. I identified that she'd never had her progesterone, oestradiol, DHEA-S, or inflammatory markers tested at specific points in her cycle. I also researched the evidence on targeted nutritional interventions: magnesium glycinate for cramping, omega-3 at therapeutic doses for prostaglandin regulation, DIM for oestrogen metabolism, and iron bisglycinate for her depleted ferritin. I wrote a 16-page briefing with the blood tests she needed, the referral pathway for a specialist in excision surgery, and a nutritional protocol with dosages and timing referenced against published trials.
The blood work confirmed oestrogen dominance and low progesterone. Within six weeks of starting the nutritional protocol, her period dropped from seven days to four. By month three, it was three days with minimal pain. She cancelled the laparoscopy referral. Her words: "I spent twelve years thinking this was just my body. It wasn't. Nobody had ever actually looked at the hormones."
A woman diagnosed with polycystic ovary syndrome at university had been on metformin and the combined pill for over a decade. She came off both at 30 because she and her partner were thinking about starting a family. Within three months her periods disappeared entirely. Her GP said "give it time." After six months of nothing, she was referred to a fertility clinic, where the first appointment was four months away. She came to me panicking that she'd left it too late.
I researched the specific PCOS phenotype she presented with (lean PCOS, which her GP had missed because she didn't fit the typical weight profile) and reviewed the evidence on insulin sensitisation, androgen reduction, and ovulatory support for her subtype. I found that her clinic had never tested fasting insulin, only fasting glucose, which looked normal. I compiled the published evidence on inositol (myo-inositol and D-chiro in a 40:1 ratio), NAC for androgen reduction, and targeted supplementation for ovulation support. I also identified a reproductive endocrinologist who specialised in lean PCOS rather than the general fertility clinic she'd been referred to. The briefing included a complete protocol with dosages, timing, and monitoring schedule.
Fasting insulin came back elevated, confirming the insulin resistance her GP had missed by only checking glucose. She started the protocol. Her first natural period arrived seven weeks later. By month four, she was cycling regularly for the first time since adolescence. She told me: "The fertility clinic was going to put me straight on Clomid. Nobody thought to check if my body could do this on its own first."
A 9-year-old boy had been diagnosed with ADHD two years prior and started on methylphenidate. The medication helped with focus and behaviour at school, but over the following 18 months he'd lost significant appetite, dropped two percentiles on his growth chart, started complaining of stomach aches, and was struggling to fall asleep. His parents had raised these concerns with his paediatrician, who said the side effects were "expected" and suggested "waiting it out." They came to me because they didn't want to choose between their son's ability to function at school and his physical health.
I researched the published literature on stimulant medication side effects in children and the evidence-based adjuncts that mitigate them without reducing efficacy. The appetite suppression and growth concerns had specific nutritional interventions backed by paediatric studies: calorie-dense meal timing around the medication window, zinc supplementation (shown to enhance methylphenidate response while supporting appetite), magnesium glycinate for the sleep onset difficulties, and omega-3 at a specific EPA:DHA ratio shown to improve ADHD symptoms independently. I also investigated whether his dose was optimal or whether a lower dose combined with these adjuncts could maintain the same benefit. The briefing included a complete protocol, a medication timing strategy, and a monitoring schedule for his parents and paediatrician.
The paediatrician agreed to the adjunct protocol after reviewing the evidence I'd compiled. Within six weeks, sleep onset improved from 45+ minutes to under 15. Appetite returned enough to stabilise his weight. His parents reported he was "calmer, not just focused" and the stomach aches stopped. The paediatrician reduced his dose by 20% and maintained the same behavioural outcomes. His mother's words: "I wish someone had given us this information on day one instead of just handing us a prescription."
Parents of a 6-year-old girl noticed she was struggling socially at school, having meltdowns at home, and showing signs of sensory sensitivity and rigid routines. The school SENCO flagged potential autism. The GP referred her for assessment, but the NHS waiting list was 22 months. The parents were told "there's nothing we can do until she's assessed." Meanwhile, she was falling behind academically and becoming increasingly distressed. They came to me because they couldn't accept watching their daughter struggle for two years while waiting for a piece of paper.
I researched the diagnostic pathway for autism in girls her age, which is commonly missed or delayed because the standard criteria were developed primarily from male presentations. I identified that girls often "mask" in school environments, which her teachers had interpreted as "coping fine." I compiled the published evidence on female autism presentation and wrote a clinical profile that her parents could present to both the school and their GP. I identified a private diagnostic team with specific expertise in girls and camouflaging behaviour, with a six-week turnaround. I also researched the nutritional and environmental factors shown in the literature to reduce sensory overload and support regulation: magnesium, B6, omega-3 at specific doses, dietary considerations around gut-brain axis research, and sensory diet strategies. I drafted the letters requesting an EHCP needs assessment and identified an occupational therapist specialising in sensory processing.
Diagnosis confirmed within eight weeks. The school implemented adjustments immediately based on the clinical profile I'd written before the formal diagnosis even came through. The EHCP process was initiated. The occupational therapist started sensory integration work. The nutritional protocol reduced her evening meltdowns noticeably within the first month. Her father told me: "The system was telling us to wait. You showed us we didn't have to."
A man in his late 30s had been on an SSRI for two years. The depression had lifted, but he'd developed persistent brain fog, muscle cramps, and a flatness he described as "I'm not sad anymore, but I'm not anything." His GP suggested switching to a different SSRI. He didn't want to start the adjustment process again. He came to me asking if there was a way to keep the medication working while addressing the new symptoms.
I researched the published literature on nutrient depletion caused by his specific SSRI. The evidence showed it was known to reduce CoQ10, magnesium, and folate levels, all of which directly affect cognitive function and energy. The "emotional blunting" he described is a recognised phenomenon with SSRIs, and recent studies showed that methylfolate supplementation at therapeutic doses can restore emotional range without reducing antidepressant efficacy. I also found that his muscle cramps were consistent with the magnesium depletion profile. I compiled the evidence on targeted adjuncts: L-methylfolate (the bioavailable form, not folic acid), magnesium glycinate, CoQ10 in ubiquinol form, and omega-3 at doses shown to support SSRI response. The briefing included every citation, dosage, timing relative to his medication, and potential interactions.
His GP approved the adjunct protocol after reviewing the evidence. The muscle cramps resolved within two weeks. The brain fog lifted over the following month. By week eight, he described feeling "like the medication is actually doing what it was supposed to do now." He stayed on the same SSRI. No switch needed. His message to me: "My GP had two options: increase the dose or change the drug. You found a third one."
A woman in her early 40s had been dealing with chronic gastritis for over a year. Burning after meals, nausea every morning, bloated within minutes of eating. She tested positive for Helicobacter pylori. Her GP prescribed standard triple therapy — amoxicillin, clarithromycin, and a proton pump inhibitor. She completed the full course. Breath test came back positive again. Second round: different antibiotic combination, same result. Still positive. Her gastroenterologist suggested a third attempt with a quadruple regimen. She came to me before starting it because, in her words, "I can't keep nuking my gut with antibiotics that aren't working."
I went through the published literature on H. pylori treatment failure. The clinical picture pointed to biofilm-mediated resistance — H. pylori forms polysaccharide biofilms in the gastric mucosa that physically shield the bacteria from antibiotics, regardless of which combination you use. The drugs reach the stomach but can't penetrate the biofilm matrix. This is well-documented in gastroenterology research but rarely discussed in standard treatment protocols. I compiled evidence on biofilm-disrupting agents that have been studied specifically alongside H. pylori eradication therapy: N-acetylcysteine (NAC) as a mucolytic that degrades the biofilm matrix, bismuth subcitrate which disrupts biofilm integrity and has direct bactericidal action, and lactoferrin which inhibits H. pylori adhesion to gastric epithelial cells. I mapped the dosing protocols from the clinical trials, the timing sequences that showed best results — NAC administered before antibiotics to break the biofilm open first, not concurrently — and the probiotic strains with evidence for preventing antibiotic-associated gut damage during eradication. Saccharomyces boulardii specifically, not generic "probiotics." I also flagged that her PPI dose may have been suboptimal for her weight and that acid suppression is critical for antibiotic efficacy in the stomach.
Her gastroenterologist reviewed the briefing and agreed to trial the biofilm disruption protocol alongside the third-round antibiotics. NAC for two weeks before starting the eradication regimen, bismuth added to the quadruple therapy, PPI dose adjusted upward. Six weeks after completing treatment, she took the breath test. Negative. First negative result in fourteen months. The gastritis symptoms had already started improving during the NAC pre-treatment phase. Three months later, no recurrence. Her message: "Two gastroenterologists couldn't figure out why the antibiotics kept failing. You found the answer in the research they weren't reading."
Whether it's a single intelligence brief or an ongoing partnership, this is what happens after you get in touch.
A 20-minute call or a detailed message. You tell me what's going on, what's worrying you, and what you need. I'll be honest about whether I can help and what it'll cost. No obligation at this stage.
You get a clear written scope: what I'll research, what you'll receive, and when you'll have it. The fee is fixed before I start. No hourly billing, no surprises, no scope creep.
I use clinical databases, published literature, specialist registries, and regulatory records. I cross-reference everything. I check interactions, track records, outcomes data, complication rates. This isn't a Google search. It's the kind of work a medical researcher would do, focused entirely on your situation.
A structured, referenced document covering everything I've found. Clear language, no jargon unless you want it. Specific recommendations. The questions to ask your consultant. The things to watch for. The options nobody told you about.
I walk you through the briefing. You ask questions. If you want ongoing support, we discuss it. If the one-time brief answered everything, that's fine too. No upselling.
Describe what you're navigating. I'll tell you honestly whether I can help, what it'll cost, and how fast I can deliver.